Healthcare
Live Price
Offline$4.41
+0.00% today
1Y Change
-42.88%
Window
Jun 20, 2025 → Jun 15, 2026
Coverage: 248 bars · Jun 20, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
111, Inc. (YI) is a Healthcare stock with a market cap of $350.00M and listed on NASDAQ. The stock last traded around $4.41 and down 42.9% across the available one-year price window (Jun 20, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of -15.2%, EPS growth of +1.3%, a dividend yield of 0.0%. What stands out right now is revenue -15.2%, EPS +1.3%, free cash flow -53.7% with operating margin -0.1% and ROIC -1.5%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines YI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
YI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
YI Max Drawdown
-68.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for YI and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$8.2B
-34.0% YoY
FY Net Income
-$456.5M
+31.8% YoY
Free Cash Flow
-$142.3M
+81.1% YoY
Revenue Growth
-15.2%
EPS Growth
+1.3%
Gross Margin
5.8%
Net Margin
-0.4%
Income statement
CNY
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 14.4B | 14.9B | 13.5B | 12.4B | 8.2B |
| Gross Profit | 829M | 448M | 840M | 621M | 366M |
| Operating Income | 2M | -350M | -371M | -642M | -473M |
| EBITDA | 25M | -311M | -322M | -588M | -459M |
| Net Income | -65M | -393M | -417M | -670M | -457M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CNY
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 462M | 604M | 674M | 661M | 1.2B |
| Total Assets | 2.8B | 3.1B | 3.5B | 3.1B | 3.0B |
| Total Liabilities | 2.4B | 2.8B | 2.8B | 2.3B | 1.7B |
| Shareholder Equity | -643M | -583M | -415M | -173M | 357M |
| Total Debt | 257M | 443M | 344M | 491M | 329M |
| Net Debt | -206M | -160M | -329M | -170M | -860M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
117M
+83.0% YoY
Capital Expenditures
26M
+59.3% YoY
Free Cash Flow
142M
+81.1% YoY
Key ratios
Gross Margin
5.8%
Operating Margin
-0.1%
Net Margin
-0.4%
ROE
8.3%
Debt / Equity
-0.31x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.